- Home
- NCZ vs TCMD Comparison
NCZ vs TCMD Comparison
Compare NCZ & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NCZ | TCMD |
|---|---|---|
| Founded | 2003 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.7M | 300.1M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | NCZ | TCMD |
|---|---|---|
| Price | $14.09 | $27.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | 50.0K | ★ 403.3K |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | ★ 12.16% | N/A |
| EPS Growth | N/A | ★ 17.14 |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.60 |
| Revenue Next Year | N/A | $9.14 |
| P/E Ratio | ★ N/A | $33.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.23 | $8.61 |
| 52 Week High | $14.99 | $37.77 |
Technical Indicators
Market Signals| Indicator | NCZ | TCMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.91 | 44.39 |
| Support Level | $13.56 | $26.47 |
| Resistance Level | $14.25 | $30.74 |
| Average True Range (ATR) | 0.32 | 1.13 |
| MACD | -0.09 | -0.18 |
| Stochastic Oscillator | 49.22 | 25.24 |
Price Performance
Historical ComparisonAbout NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.